Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients

Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients

Dimitrios Chantzichristos, Andr&eacute;asson Bj&ouml;rn, Johansson PeterDepartment of Internal Medicine, Uddevalla Hospital, Uddevalla, SwedenBackground: Once a month, patients with multiple myeloma received an infusion of bisphosphonates, principally to reduce osteoclastic bone reso...

Full description

Bibliographic Details
Main Authors:	Dimitrios Chantzichristos, Andr&eacute;asson Bj&ouml;rn, Johansson Peter
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-09-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/safe-and-tolerable-one-hour-pamidronate-infusion-for-multiple-myeloma--a2267

Similar Items

Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta
by: Chia-Hsuan Lin, et al.
Published: (2014-08-01)

Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
by: Ji-Hee Yoon, et al.
Published: (2021-06-01)

Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise
by: Mansour Salesi, et al.
Published: (2011-01-01)

Acute Pancreatitis Occurring after Pamidronate Infusions in Two Patients with Spondyloarthritis
by: Éric Toussirot, et al.
Published: (2013-01-01)

In silico investigations of the anti-catabolic effects of pamidronate and denosumab on multiple myeloma-induced bone disease.
by: Yan Wang, et al.
Published: (2012-01-01)

Intravenous pamidronate for refractory rheumatoid arthritis
by: Mansour Salesi, et al.
Published: (2012-01-01)

Therapy with pamidronate in children with osteogenesis imperfecta
by: Marginean O, et al.
Published: (2017-08-01)

Pamidronate “zebra lines”: A treatment timeline
by: Avgi Loizidou, BSc, MBChB, et al.
Published: (2017-12-01)

Advances in safe insulin infusions
by: Fred Massoomi, et al.
Published: (2021-07-01)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
by: Marco A, et al.
Published: (2008-09-01)

Sternocostoclavicular Hyperostosis: Positive Clinical and Radiological Response on Pamidronate
by: Anne T. Leerling, et al.
Published: (2021-02-01)

Effect of pamidronate and calcium on implant osseointegration in ovariectomized rats
by: Mehrnoush Momeni, et al.
Published: (2016-09-01)

Effect of Pamidronate on Bone Pain in Patients with Bone Metastasis
by: Shahrbanoo Keihanian, et al.
Published: (2013-06-01)

Osteogenesis Imperfecta in Adult Twins Responded To Treatment With Pamidronate
by: Mehtap Çakır, et al.
Published: (2011-06-01)

Effect of Pamidronate on Hypercalcemia, BUN and Cr in Patients with Malignancy
by: Shahrbanoo Keyhanian, et al.
Published: (2016-05-01)

Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
by: Hsiang-Yu Lin, et al.
Published: (2008-10-01)

Comparison of Calcitonin and Pamidronate Treatments in Children with Osteogenesis Imperfecta
by: Neslihan Onenli Mungan, et al.
Published: (2013-08-01)

The Positive Effects of One-Hour Intravenous Administration of Bortezomib on Peripheral Neuropathy in Multiple Myeloma Patients
by: Joo Young Jung, et al.
Published: (2014-01-01)

Treatment of the low bone mineral density with intravenous pamidronate in pediatric patients: review of a protocol of a single-day infusion twice a year
by: Ricart S, et al.
Published: (2008-09-01)

Comparison of the effect of alendronate and pamidronate on bone density of patients with osteoporosis
by: Zohre Nobakht, et al.
Published: (2018-12-01)

Use of pamidronate for osteoporosis treatment in public health care in Brazil
by: Leila Bianchet Zanatta, et al.

Pamidronate-Conjugated Biodegradable Branched Copolyester Carriers: Synthesis and Characterization
by: Ewa Oledzka, et al.
Published: (2017-06-01)

Pamidronate Disodium for Palliative Therapy of Feline Bone-Invasive Tumors
by: Jackie M. Wypij, et al.
Published: (2014-01-01)

Pamidronate Rescue Therapy for Hypercalcemia in a Child With Williams Syndrome
by: Sami A. Sanjad, et al.
Published: (2018-05-01)

Extraction socket healing in pediatric patients treated with intravenous pamidronate
by: Chahine, Carol Judith
Published: (2012)

Two resource distribution strategies for dynamic mitigation of influenza pandemics
by: Andr&eacute;s Uribe-S&aacute;nchez, et al.
Published: (2010-07-01)

A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice
by: Bod&eacute;n R, et al.
Published: (2013-03-01)

Treatment of osteogenesis imperfecta with intravenous pamidronate in pediatric patients: comparison between a single-day infusion twice a year protocol with other regimens described in the literature
by: Ricart S, et al.
Published: (2008-09-01)

Managing anemia in lymphoma and multiple myeloma
by: Gunnar Birgeg&aring;rd
Published: (2008-04-01)

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
by: Ribas Antoni, et al.
Published: (2012-11-01)

Preparation and Biodistribution of 99mTc-Pamidronate as Bone Imaging Agent
by: LUO Hong-yi, et al.
Published: (2016-02-01)

Use of disodium pamidronate bisphosphonate in patients with bone metastases of lung cancer
by: Ranković Boško, et al.
Published: (2002-01-01)

Amelioration of Hypophosphatemic Rickets and Osteoporosis With Pamidronate and Growth Hormone in Lowe Syndrome
by: Jia-Woei Hou
Published: (2009-09-01)

Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
by: Se Won Lim, et al.
Published: (2016-03-01)

Evaluation of Two Different Pamidronate Treatment Protocols in Children with Osteogenesis Imperfecta
by: Neslihan Onenli Mungan, et al.
Published: (2014-06-01)

Re-evaluated data of dissociation constants of alendronic, pamidronic and olpadronic acids
by: Boichenko Alexander, et al.
Published: (2009-03-01)

The presence of pamidronate in bone cement affects serum biochemical markers in the rat
by: Matuszewski Łukasz, et al.
Published: (2014-06-01)

Donor Lymphocyte Infusion to Enhance the Graft-versus-Myeloma Effect
by: Nico Gagelmann, et al.
Published: (2021-04-01)

Bisphosphonate-induced femoral fragility fractures: What do we know?
by: Arkan S Sayed-Noor, et al.
Published: (2010-03-01)

Lenalidomide for the treatment of relapsed and refractory multiple myeloma
by: van de Donk NW, et al.
Published: (2012-08-01)

Cannot write session to /tmp/vufind_sessions/sess_7bl4nqvqfqaem6i7p961b73ntl